Kookmin Bio Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$2.45M
- Investors
-
6
Kookmin Bio General Information
Description
Developer of microbiome-regulating materials and new drugs intended for preventive medicines. The company secures differentiated strain development, fermentation production technology, and core processes centering on the commercialization of biopharmaceutical materials that resolve the imbalance of the intestinal microflora, enabling patients to put life and health first.
Contact Information
Website
www.kmbio.co.krCorporate Office
- Room 116, Main Building, Jeonju National University
- 303 Cheonjam-ro, Wansan-gu
- Jeonju, Jeollabuk
- South Korea
Corporate Office
- Room 116, Main Building, Jeonju National University
- 303 Cheonjam-ro, Wansan-gu
- Jeonju, Jeollabuk
- South Korea
Kookmin Bio Timeline
Kookmin Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series B) | 20-Nov-2024 | $2.45M | Completed | Generating Revenue | ||
| 4. Early Stage VC (Series A) | 26-Oct-2023 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 21-Apr-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 18-Nov-2021 | Completed | Generating Revenue | |||
| 1. Seed Round | 22-Jan-2019 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Kookmin Bio Patents
Kookmin Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026110978-A1 | Composition for regulating and improving blood glucose | Pending | 22-Nov-2024 |
Kookmin Bio Signals
Kookmin Bio Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Industrial Bank of Korea | PE/Buyout | Minority | ||
| KGROUND Ventures | Venture Capital | Minority | ||
| Kookmin University Technology Holdings | Venture Capital | Minority | ||
| Korea Alternative Investment Corporation | Asset Manager | Minority | ||
| Tech Incubator Program for Startup | Accelerator/Incubator |
Kookmin Bio FAQs
-
When was Kookmin Bio founded?
Kookmin Bio was founded in 2019.
-
Where is Kookmin Bio headquartered?
Kookmin Bio is headquartered in Jeonju, South Korea.
-
What is the size of Kookmin Bio?
Kookmin Bio has 13 total employees.
-
What industry is Kookmin Bio in?
Kookmin Bio’s primary industry is Drug Discovery.
-
Is Kookmin Bio a private or public company?
Kookmin Bio is a Private company.
-
What is Kookmin Bio’s current revenue?
The current revenue for Kookmin Bio is .
-
How much funding has Kookmin Bio raised over time?
Kookmin Bio has raised $4.03M.
-
Who are Kookmin Bio’s investors?
Industrial Bank of Korea, KGROUND Ventures, Kookmin University Technology Holdings, Korea Alternative Investment Corporation, and Tech Incubator Program for Startup are 5 of 6 investors who have invested in Kookmin Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process